Mark Verratti - Apr 14, 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Commercial Officer
Signature
By: Nathan A. Smith For: Mark Verratti
Stock symbol
MYGN
Transactions as of
Apr 14, 2022
Transactions value $
$0
Form type
4
Date filed
4/14/2022, 05:00 PM
Previous filing
Mar 25, 2022
Next filing
Aug 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +10K +4.29% $0.00 243K Apr 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.